Business news
The latest business news from across the chemistry-using industries, including mergers and acquisitions, legal and patent disputes, regulation and commercial performance, from the Royal Society of Chemistry's magazine, Chemistry World
-
OpinionDeadly reminders of the importance of risk assessment
Serious incidents in two university labs highlight the importance of knowing what to do when things go wrong
-
BusinessUS approves pancreatic cancer treatment that targets ‘undruggable’ proteins
Daraxonrasib success offers hope of further approvals for Ras-inhibitor drug candidates targeting various cancers
-
BusinessAntibody data manipulation extends to thousands of images across 15 suppliers
Sleuths discover widespread, systematic alteration of Western blots and other antibody data
-
BusinessProtein degrader approval offers hope to relapsed multiple myeloma patients
Highly potent molecular glue drug iberdomide doubles the number of patients reaching fewer than one myeloma cell per 100,000 in bone marrow
-
OpinionChemistry contains multitudes
There’s room (and need) for all the various subspecies of chemical scientists
-
BusinessInvestigation flags chemical incompatibility in deadly US incident
Mixing nitric acid with sodium trithiocarbonate at Catalyst Refiners formed hydrogen sulfide
-
OpinionArtificial intelligence or clever artifice?
It’s important to be realistic about what AI can, and can’t, achieve, across the chemistry enterprise
-
BusinessRecord low European river levels threaten chemical freight and process cooling
Cutting off bulk barges leaves few options for high-volume gaseous cargoes, where road and rail options are unsuitable
-
BusinessCombining AI with experiments to solve real-world materials problems
CuspAI’s Materials Foundry partner network includes 45 technology, data and materials chemistry companies to make and test its predictions
-
OpinionMessy megamergers
Rumoured merger between AstraZeneca and Bristol Myers Squibb has collapsed, and that’s probably a good thing
-
BusinessOral cholesterol-lowering peptide approved after a decade in development
Merck & Co’s Lipfendra (enlicitide) employs 13 enzymes in biocatalytic synthesis
-
PodcastThermo Fisher data manipulation & the shrinking chemical recycling industry
We discuss fabricated images in Thermo Fisher’s online catalogue. And, what barriers are preventing chemical plastic recycling from taking off?
-
OpinionTrump threatens generic drug tariffs
Plan aims to encourage domestic US supplies, but will it work?
-
BusinessEU relaxes methane and carbon emission rules
Methane regulation fines delayed carbon trading restrictions eased amid concerns over energy supply and security
-
BusinessJ&J proposes $5.5 billion settlement deal for talc cancer lawsuits
Deal would resolve 76,000 cases of women claiming talc caused ovarian cancer
-
BusinessIndia’s generic GLP-1 drugs are (mostly) booming
Manufacturing problems for some manufacturers have led to production pauses and recalled batches of diabetes and weight loss drugs
-
OpinionWhere does chemical recycling of plastics go from here?
US and EU plant closures highlight economic difficulties of scaling technology alongside associated policy and infrastructure
-
Business2024 Bio-Lab fire and chemical plume caused by improper chemical storage
Investigation finds site was storing almost double its rated capacity of reactive pool chemicals
-
BusinessChemical recycling plants closing in EU and US
Firms aiming to break down and re-make plastics are struggling with economic feasibility and environmental impact
-
OpinionTrust is easily broken and hard to rebuild
Thermo Fisher needs to be open and honest about data manipulation to reassure researchers